234 related articles for article (PubMed ID: 14552429)
1. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.
Vardiman JW
Semin Diagn Pathol; 2003 Aug; 20(3):154-79. PubMed ID: 14552429
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Găman M; Vlădăreanu AM; Radesi S
Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
[TBL] [Abstract][Full Text] [Related]
4. Issues in the pathology of the myelodysplastic syndromes.
Kampmeier P; Anastasi J; Vardiman JW
Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
[TBL] [Abstract][Full Text] [Related]
5. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.
Kuzmich PV; Ecker GA; Karsh J
J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders.
Kikuchi M
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1339-46. PubMed ID: 3247814
[No Abstract] [Full Text] [Related]
7. [Myelodysplastic syndromes--from FAB to WHO classification].
Kotlarek-Haus S; Haus O
Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
[No Abstract] [Full Text] [Related]
8. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
Sangiorgio VFI; Orazi A; Arber DA
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic/myeloproliferative neoplasms.
Cazzola M; Malcovati L; Invernizzi R
Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
[TBL] [Abstract][Full Text] [Related]
10. The bone marrow in myeloproliferative and dysmyelopoietic syndromes.
Wolf BC; Neiman RS
Hematol Oncol Clin North Am; 1988 Dec; 2(4):669-94. PubMed ID: 3065324
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
Dirnhofer S; Went P; Tichelli A
Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
[TBL] [Abstract][Full Text] [Related]
12. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable; rare cause of granulocytic sarcoma: A diagnostic dilemma.
Mandal PK; Kumar M; Bhattyacharyya M
Indian J Pathol Microbiol; 2016; 59(1):133-4. PubMed ID: 26960664
[No Abstract] [Full Text] [Related]
14. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
Reddy VV
Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
[TBL] [Abstract][Full Text] [Related]
15. [Panmyelopathy and myeloproliferative syndrome].
Jorke D; Bach G
Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
[TBL] [Abstract][Full Text] [Related]
16. [Histopathology and clinical aspects of primary myelodysplastic syndrome].
Maschek H; Georgii A
Pathologe; 1995 Jan; 16(1):53-61. PubMed ID: 7886015
[TBL] [Abstract][Full Text] [Related]
17. The challenging task of enumerating blasts in the bone marrow.
Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
[TBL] [Abstract][Full Text] [Related]
18. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
Loghavi S; Wang SA
Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
[TBL] [Abstract][Full Text] [Related]
19. Progenitor cells and classification of myelodysplastic and myeloproliferative disorders.
Brown G; Bunce CM; Rose PE; Howie AJ
Lancet; 1985 Oct; 2(8460):885. PubMed ID: 2864593
[No Abstract] [Full Text] [Related]
20. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
